Eli Lilly Financials
| LLY Stock | EUR 767.80 2.90 0.38% |
Eli |
You should never invest in Eli Lilly without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Eli Stock, because this is throwing your money away. Analyzing the key information contained in Eli Lilly's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Eli Lilly Key Financial Ratios
There are many critical financial ratios that Eli Lilly's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Eli Lilly reports annually and quarterly.Eli Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Eli Lilly's current stock value. Our valuation model uses many indicators to compare Eli Lilly value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eli Lilly competition to find correlations between indicators driving Eli Lilly's intrinsic value. More Info.Eli Lilly and is considered the number one company in current valuation category among its peers. It also is currently regarded as number one stock in price to book category among its peers . The ratio of Current Valuation to Price To Book for Eli Lilly and is about 9,628,269,936 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eli Lilly's earnings, one of the primary drivers of an investment's value.Eli Lilly Systematic Risk
Eli Lilly's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Eli Lilly volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Eli Lilly correlated with the market. If Beta is less than 0 Eli Lilly generally moves in the opposite direction as compared to the market. If Eli Lilly Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Eli Lilly is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Eli Lilly is generally in the same direction as the market. If Beta > 1 Eli Lilly moves generally in the same direction as, but more than the movement of the benchmark.
Eli Lilly December 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Eli Lilly help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Eli Lilly and. We use our internally-developed statistical techniques to arrive at the intrinsic value of Eli Lilly and based on widely used predictive technical indicators. In general, we focus on analyzing Eli Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Eli Lilly's daily price indicators and compare them against related drivers.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 12.72 | |||
| Value At Risk | (3.46) | |||
| Potential Upside | 3.64 |
Additional Information and Resources on Investing in Eli Stock
When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.